---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-029606"
form_type: "8-K"
ticker: "AVTX"
cik: "0001534120"
company_name: "Avalo Therapeutics, Inc."
filed_at: "2022-11-14T23:59:59+00:00"
generated_at: "2026-06-21T20:03:28.647559+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Avalo Therapeutics sells AVTX-501 milestones and AVTX-007 royalties to ES Therapeutics for $5M

## Summary
- Closed sale to ES Therapeutics (Armistice affiliate) of rights to milestones from Janssen (AVTX-501) and royalty payments from Apollo (AVTX-007).
- Waived all rights under AVTX-611 license agreement with ES and Armistice.
- Received $5.0M cash payment upon closing on November 10, 2022.
- Board approved under related party policy; Armistice is a significant stockholder.

## SEC filing metadata
- accession: 0001628280-22-029606
- form_type: 8-K
- ticker: AVTX
- cik: 0001534120
- company_name: Avalo Therapeutics, Inc.
- filed_at: 2022-11-14T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534120/000162828022029606/0001628280-22-029606-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534120/000162828022029606/avtx-20221110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-029606
- JSON: https://secwatch.observer/filing/0001628280-22-029606.json
- Plain text: https://secwatch.observer/filing/0001628280-22-029606.txt

## Key facts
- M&A Transactions
  Avalo Therapeutics, Inc. completed a disposition involving ES Therapeutics, LLC for $5.0 million (closed 2022-11-10).
  - Action: disposition
  - Counterparty: ES Therapeutics, LLC
  - Consideration: $5.0 million
  - Closing: 2022-11-10
  source text: The transaction closed on November 10, 2022 and the Company has received the $5.0 million payment from ES.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534120/000162828022029606/0001628280-22-029606-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.